Skip to main content

Table 3 Baseline characteristics

From: The cardioprotective effects of HTK solution and conventional blood cardioplegia in patients with atrial fibrillation undergoing valvular replacement and Cox maze III procedure

Characteristics

Entire population

Propensity-matched population

HTK (n = 81)

BC (n = 67)

P

HTK (n = 53)

BC (n = 53)

P

n %

n %

n %

n %

Age (years)

≤ 55

37

45.70

43

64.20

0.02

27

50.90

31

58.50

0.44

> 55

44

54.30

24

35.80

26

49.10

22

41.50

Gender

Male

36

44.40

29

43.30

0.89

29

54.70

24

45.30

0.33

Female

45

55.60

38

56.70

24

45.30

29

54.70

BMI

≤ 23.375

40

49.40

34

50.70

0.87

26

49.10

24

45.30

0.69

> 23.375

41

50.60

33

49.30

27

50.90

29

54.70

Smoke

no

57

70.40

47

70.10

0.98

33

62.30

36

67.90

0.54

yes

24

29.60

20

29.90

20

37.70

17

32.10

Hypertension

no

73

90.10

60

89.60

0.91

46

86.80

50

94.30

0.18

yes

8

9.90

7

10.40

7

13.20

3

5.70

Diabetes

no

75

92.60

62

92.50

0.99

48

90.60

49

92.50

0.73

yes

6

7.40

5

7.50

5

9.40

4

7.50

Cerebral Infarction

no

67

82.70

50

74.60

0.23

40

75.50

46

86.80

0.14

yes

14

17.30

17

25.40

13

24.50

7

13.20

  1. BMI, Body Mass Index